HER2-positive Metastatic Breast Cancer trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All HER2-positive Metastatic Breast Cancer trials nationally

Cities in Illinois

Recruiting trials in Illinois

• PRE-ISPY Phase I/II Oncology Platform Program
  NCT05868226 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, New Lenox, Orland Park
• QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
  NCT06551116 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, New Lenox, Orland Park